These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36215268)

  • 21. Intramuscular immunization of mice with live influenza virus is more immunogenic and offers greater protection than immunization with inactivated virus.
    Harris K; Ream R; Gao J; Eichelberger MC
    Virol J; 2011 May; 8():251. PubMed ID: 21600020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.
    Budimir N; Huckriede A; Meijerhof T; Boon L; Gostick E; Price DA; Wilschut J; de Haan A
    PLoS One; 2012; 7(1):e30898. PubMed ID: 22303469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines.
    Cox RJ; Brokstad KA; Ogra P
    Scand J Immunol; 2004 Jan; 59(1):1-15. PubMed ID: 14723616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine.
    Tamura SI; Asanuma H; Ito Y; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T; Oya A
    Eur J Immunol; 1992 Feb; 22(2):477-81. PubMed ID: 1537382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.
    Ichinohe T; Tamura S; Kawaguchi A; Ninomiya A; Imai M; Itamura S; Odagiri T; Tashiro M; Takahashi H; Sawa H; Mitchell WM; Strayer DR; Carter WA; Chiba J; Kurata T; Sata T; Hasegawa H
    J Infect Dis; 2007 Nov; 196(9):1313-20. PubMed ID: 17922395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections.
    Tseng YC; Wu CY; Liu ML; Chen TH; Chiang WL; Yu YH; Jan JT; Lin KI; Wong CH; Ma C
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4200-4205. PubMed ID: 30782805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.
    Kim EH; Park HJ; Han GY; Song MK; Pereboev A; Hong JS; Chang J; Byun YH; Seong BL; Nguyen HH
    J Virol; 2014 Sep; 88(17):9693-703. PubMed ID: 24920793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral or intranasal immunization with recombinant Lactobacillus plantarum displaying head domain of Swine Influenza A virus hemagglutinin protects mice from H1N1 virus.
    Zhang Y; Yang L; Zhang J; Huang K; Sun X; Yang Y; Wang T; Zhang Q; Zou Z; Jin M
    Microb Cell Fact; 2022 Sep; 21(1):185. PubMed ID: 36085207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection.
    Hong SH; Byun YH; Nguyen CT; Kim SY; Seong BL; Park S; Woo GJ; Yoon Y; Koh JT; Fujihashi K; Rhee JH; Lee SE
    Vaccine; 2012 Jan; 30(2):466-74. PubMed ID: 22051136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous immunisation with zymosan generates mucosal IgA-eliciting memory and protects mice from heterologous influenza virus infection.
    Nihei Y; Higashiyama M; Miyauchi K; Haniuda K; Suzuki Y; Kubo M; Kitamura D
    Int Immunol; 2023 Aug; 35(8):377-386. PubMed ID: 37140172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the usefulness of intranasal inactivated influenza vaccines.
    Tamura S
    Vaccine; 2010 Aug; 28(38):6393-7. PubMed ID: 20493820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal Administration of Whole Inactivated Influenza Virus Vaccine as a Promising Influenza Vaccine Candidate.
    Ainai A; Suzuki T; Tamura SI; Hasegawa H
    Viral Immunol; 2017; 30(6):451-462. PubMed ID: 28650274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine Cross-Reactive Nonneutralizing Polyclonal IgG1 Antibodies Induced by Influenza Vaccine Inhibit the Cross-Protective Effect of IgG2 against Heterologous Virus in Mice.
    Shibuya M; Aoshi T; Kuroda E; Yoshioka Y
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines.
    Dong W; Bhide Y; Sicca F; Meijerhof T; Guilfoyle K; Engelhardt OG; Boon L; de Haan CAM; Carnell G; Temperton N; de Vries-Idema J; Kelvin D; Huckriede A
    Front Immunol; 2018; 9():2312. PubMed ID: 30356772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines.
    Nogales A; DeDiego ML; Topham DJ; Martínez-Sobrido L
    J Virol; 2016 Jul; 90(14):6291-6302. PubMed ID: 27122587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice.
    Tamura S; Asanuma H; Ito Y; Yoshizawa K; Nagamine T; Aizawa C; Kurata T
    Vaccine; 1994 Mar; 12(4):310-6. PubMed ID: 8178552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination.
    Hirabayashi Y; Kurata H; Funato H; Nagamine T; Aizawa C; Tamura S; Shimada K; Kurata T
    Vaccine; 1990 Jun; 8(3):243-8. PubMed ID: 2363302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.